Skip to main content

Table 2 Dose-volume histogram data for planning target volumes in the 749 patients with NPC

From: Prognostic factors and failure patterns in non-metastatic nasopharyngeal carcinoma after intensity-modulated radiotherapy

Variate

Volume (mL)

Dmax (Gy)

Dmin (Gy)

Mean dose (Gy)

PTV-P

51.89 (2.60–287.48)

79.91 (70.47–93.95)

59.79 (50.58–71.16)

73.11 (68.16–78.48)

PTV1

97.35 (13.78–494.77)

79.67 (72.81–86.08)

58.86 (49.13–67.32)

67.94 (56.66–74.48)

PTV2

368.97 (106.36–685.58)

78.99 (70.04–86.74)

45.28 (43.12–61.47)

60.55 (53.64–72.13)

  1. PTV-P planning target volume of the primary tumor, PTV1 PTV of the high-risk clinical target volume, PTV2 PTV of the low-risk clinical target volume, D max maximum dose, D min minimum dose. All data are presented as median with range in parentheses
Back to article page

Cancer Communications

ISSN: 2523-3548

Contact us